Similar articles

• In brief: Suspension of Johnson & Johnson COVID-19 vaccine lifted.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 May 17;63(1624):e1. Med Lett Drugs Ther. 2021. PMID: 33976095 No abstract available.
• FDA authorizes Johnson & Johnson COVID-19 vaccine.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2021 Mar 22;63(1620):41-42. Med Lett Drugs Ther. 2021. PMID: 33976088 No abstract available.
• Updated Recommendations from the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis with Thrombocytopenia Syndrome Among Vaccine Recipients - United States, April 2021.

  MacNeil JR, Su JR, Broder KR, Guh AY, Gargano JW, Wallace M, Hadler SC, Scobie HM, Blain AE, Moulia D, Daley MF, McNally VV, Romero JR, Talbot HK, Lee GM, Bell BP, Oliver SE. MacNeil JR, et al. MMWR Morb Mortal Wkly Rep. 2021 Apr 30;70(17):651-656. doi: 10.15585/mmwr.mm7017e4. MMWR Morb Mortal Wkly Rep. 2021. PMID: 33914723 Free PMC article.
• Vaccine safety - is the SARS-CoV-2 vaccine any different?

  Tau N, Yahav D, Shepshelovich D. Tau N, et al. Hum Vaccin Immunother. 2021 May 4;17(5):1322-1325. doi: 10.1080/21645515.2020.1829414. Epub 2020 Dec 3. Hum Vaccin Immunother. 2021. PMID: 33270474 Free PMC article. Review.
• [COVID-19 vaccines and cancer patients: State of the art and guidelines summary].

  Kharmoum S, El M'Rabet FZ. Kharmoum S, et al. Bull Cancer. 2021 May;108(5):553-555. doi: 10.1016/j.bulcan.2021.03.008. Epub 2021 Apr 8. Bull Cancer. 2021. PMID: 33902920 Free PMC article. Review. French. No abstract available.